Acufocus Submits PMA to FDA for Approval of the Kamra Inlay

AcuFocus, Inc., has submitted the final module of their premarket approval application for the Kamra corneal inlay to the Food and Drug Administration (FDA). Over time, everyone will experience loss of reading vision and blurriness, or presbyopia, as they age. The Kamra corneal inlay is designed to revive reading vis...

Full Story →